Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Biosearch Technologies Launches New, ISO Certified GMP Production Facility

Published: Thursday, April 18, 2013
Last Updated: Thursday, April 18, 2013
Bookmark and Share
Biosearch Technologies, Inc. (Biosearch) announced the relocation of its GMP manufacturing process into a new, state-of-the-art GMP production facility in Novato, California.

The 30,000 square foot facility was developed to further expand processes and controls relevant to medical device and molecular diagnostic customers.

“The GMP production facility is designed to incorporate the environmental and access controls, linear production flow and clean room processes critical for the controlled manufacture of highly-qualified diagnostic components, reagents and kits,” said Ron Cook, President and CEO of Biosearch Technologies.  “Our new facility allows us to continue to support our diagnostic customers in a manner fully compliant with customer and regulatory requirements.  This advanced facility also introduces pharmaceutical scale lyophilization capabilities allowing for state-of-the-art processing of molecular diagnostic assays in large scale single batches and all format types.”

In addition to the relocation to the new GMP production facility, Biosearch has successfully completed certification to ISO 13485:2003.  This certification confirms that Biosearch has developed, implemented and maintains a Quality Management System able to meet the stringent requirements of medical device and molecular diagnostic manufacturing.

“Certification to ISO 13485 is a significant milestone for Biosearch and its GMP and Commercial Services production group,” said Jason Erickson, Director of Quality at Biosearch Technologies.  “We have taken great strides to ensure a robust Quality Management System and successful certification to this standard demonstrates our commitment to quality at all levels within our organization.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Biosearch Announces Acquisition of European Companies DNA Technology and VitraBio
Acquisition marks Company’s increasing commitment to support European biotechnology and diagnostic markets.
Tuesday, July 23, 2013
Biosearch Technologies Licenses RNA FISH-based Inventions from UMDNJ
Stellaris® Probe alliance - NextGen Gene Expression™, SNP FISH™, and iceFISH™ in research and clinical applications.
Tuesday, March 19, 2013
Biosearch Acquires Worldwide Rights to Non-FRET Probes Patents
Company has acquired rights from UMDNJ to United States Patent 6,150,097.
Thursday, August 23, 2012
Biosearch Appoints Uniscience as Brazilian Distributor
Uniscience to sell, market, and support Biosearch’s inventoried and custom products in the country of Brazil.
Tuesday, May 22, 2012
Biosearch and IMDx Finalize cGMP Oligo Supply and Licensing Agreements for IVD Products
Biosearch will manufacture cGMP oligonucleotides for IMDx for use in human in-vitro diagnostics.
Wednesday, March 16, 2011
Biosearch Technologies Licenses Access to new CDC “PDM” H1N1 Signatures
New “pdm” panel is optimized to achieve enhanced sensitivity and specificity for H1N1 specimen.
Friday, November 19, 2010
Biosearch Technologies and DuPont Qualicon Finalize Scorpion Supply and BHQ, CAL Fluor and Quasar Licensing Agreements for Food Safety Diagnostics
Biosearch Technologies Inc. today announced that the company has licensed access to the BHQ®, CAL Fluor® and Quasar® patents to DuPont Qualicon.
Thursday, October 28, 2010
Biosearch and Seegene Finalize Oligonucleotide Supply and BHQ®, CAL Fluor® and Quasar® Licensing Agreements
Biosearch will manufacture both research and IVD grade oligonucleotides for Seegene.
Thursday, October 21, 2010
Biosearch Technologies Awarded Second Phase II Army SBIR Grant
The $750,000+ Phase II grant will continue the design and development of accurate assays for pathogens of military importance.
Thursday, October 14, 2010
Biosearch Technologies Awarded Phase II Army SBIR Grant
The $800,000+ Phase II grant is aimed to back the design and development of rapid and accurate assays for pathogens of military importance.
Thursday, September 23, 2010
Biosearch Technologies Expands Licensing of QIAGEN Scorpions®
According to the agreement, the company obtains rights to manufacture primer assays for research, applied markets and infectious diseases.
Friday, August 13, 2010
Biosearch Technologies Signs Exclusive License for Single Molecule FISH Technologies from UMDNJ
Biosearch owns the exclusive rights to manufacture, catalogue and sell validated RNA FISH probes, assays and kits.
Sunday, August 08, 2010
Biosearch Expands Licensing of Roche Patents to Manufacture Kits Targeting the in-vitro Diagnostic Industry
License allows Biosearch to develop kits comprising of probes, primers, enzymes to amplify and detect diagnostic targets.
Wednesday, March 10, 2010
Biosearch Technologies Issued Two new Patents
The new patents comprise “Luminescent Metal Ion Complexes” and “Inducible fluorescence assay.”
Tuesday, March 09, 2010
Biosearch Technologies Selected for SBIR Grants Issued by the DoD for Disease Detection
Both the Phase I grants aim to develop sensitive analyte specific reagents for a total of twelve pathogens of military importance.
Friday, October 09, 2009
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Flu Vaccine May Reduce Risk of Death For Type 2 Diabetes Patients
Researchers at Imperial College London have suggested that the vaccine may have substantial benefits for patients with long-term conditions.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Porphyrins as Catalysts in Scalable Organic Reactions
This review covers the most relevant scalable porphyrin-catalysed procedures, showing how these compounds represent broad applications in chemistry.
CDC Updates Zika Recommendations
CDC has issued updated Zika recommendations and guidance for healthcare providers with a focus on sexual transmission.
Exploiting Malaria’s Achilles’ Heel
Researchers have uncovered an Achilles' heel in malaria's anti-drug treatment arsenal that could lead to a disease cure.
Genome of 6000-Year-Old Barley Sequenced
Researchers have successfully sequenced the genome of Chalcolithic barley grains for the first time.
3D Models May Yield Ovarian Cancer Insights
Researchers are developing new tools to decipher ovarian cancer developments through a 3D printing technology.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Plant Compounds Fight Together Against Colon Cancer
Research shows treating colon cancer cells with curcumin, then silymarin is more effective than treatment with each individually.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!